Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Merdeka Gold Resources Tbk. (EMAS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Merdeka Gold Resources Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Merdeka Gold Resources Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Merdeka Gold Resources Tbk. trades at Rp8,750 (market cap 126.69T, 21.27M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Merdeka Gold Resources Tbk. is far larger — about 10.3× Tempo Scan Pacific Tbk.'s market cap, and Merdeka Gold Resources Tbk. is more actively traded (21.27M versus 1.41M). Which is the better fit depends on your goals.

EMASTSPC
Market Cap
126.69T12.36T
Volume
21.27M1.41M
Lot
212.69K14.08K
Turnover
185.05B3.83B
Average Price
8,700.432,722.04
Value
185.05B3.83B
Indicative Equilibrium Price
8,7502,730
Indicative Equilibrium Volume
10.1K2.51K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EMAS
View details
TSPC
View details

About Merdeka Gold Resources Tbk.

PT Merdeka Gold Resources Tbk (formerly PT Pani Bersama Jaya) (the Company), was established in Republic of Indonesia based on Deed of Establishment No. 87 dated 20 November 2015 made before Humberg Lie, S.H., S.E., M.Kn., Notary in North Jakarta. The ultimate parent entity of the Company is PT Merdeka Copper Gold Tbk (MCG). Meanwhile, MCG is jointly controlled by PT Provident Capital Indonesia and PT Saratoga Investama Sedaya Tbk, which are respectively controlled by Winato Kartono and Edwin Soeryadjaya.

Read more on EMAS

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC